Blog
RSS FeedPosted by Michael Wonder on 21 Feb 2017
Massive support for NZ drug-buying agency PHARMAC to fund pads and tampons
21 February 2017 - Nearly 10,000 people have responded to a 1 NEWS Facebook poll that asked if tampons and sanitary ...
Posted by Michael Wonder on 21 Feb 2017
NICE draft guidelines reject Ipsen’s Cabometyx
21 February 2017 - NICE has issued its first draft guidelines on Ipsen's Cabometyx, recommending against the drug's routine use ...
Posted by Michael Wonder on 20 Feb 2017
Australia is on target to eliminate hepatitis C by 2026
20 February 2017 - More than 30,000 hepatitis C patients in Australia have been treated with revolutionary drugs since their listing ...
Posted by Michael Wonder on 20 Feb 2017
Big pharma funding biases drug trials in favour of a sponsor's product: review
21 February 2017 - Drug and device trial studies that are sponsored by the pharmaceutical industry are more likely to ...
Posted by Michael Wonder on 20 Feb 2017
PHARMAC considers funding women's hygiene products
20 February 2017 - PHARMAC is considering funding women's hygiene products as the cost leaves some resorting to rags and ...
Posted by Michael Wonder on 19 Feb 2017
Public hospital funding crisis highlights need for reforms
17 February 2017 - The AMA public hospital report card released today highlights that our hospitals and broader health system ...
Posted by Michael Wonder on 19 Feb 2017
Request for supply - supply of nicotine replacement therapy
20 February 2017 - PHARMAC invites proposals for the supply of nicotine replacement therapy (NRT) - including, but not limited to, ...
Posted by Michael Wonder on 18 Feb 2017
The refusal of Medicare to fund a $60 blood test means cancer patients miss out on treatment
19 February 2017 - Mother of two Lisa Briggs and thousands of other lung cancer patients battling the nation’s deadliest ...
Posted by Michael Wonder on 18 Feb 2017
When is applying for listing on the Pharmaceutical Benefits Scheme not an infringement?
16 February 2017 - In the most recent judgement in the Australian Lyrica litigation, Nicholas J has delivered an interesting decision ...
Posted by Michael Wonder on 17 Feb 2017
PBS botulinum toxin program changes
17 February 2017 - Changes are being made under the PBS Botulinum Toxin Program to enable eligible prescribers to write more ...
Posted by Michael Wonder on 15 Feb 2017
NICE rejects Alexion’s rare disease therapy Kanuma
15 February 2017 - NICE has published a final evaluation determination rejecting the use of Alexion's Kanuma to treat infants, ...
Posted by Michael Wonder on 15 Feb 2017
NICE publishes draft guidance for Venclyxto
15 February 2017 - The Department of Health has asked NICE to produce guidance on using venetoclax in the NHS in ...
Posted by Michael Wonder on 15 Feb 2017
Private health insurance rises prompt launch of tool aimed at reducing costs
15 February 2017 - Consumers Health Forum checklist will help people decide whether to keep their policy, switch, or drop it ...
Posted by Michael Wonder on 15 Feb 2017
March 2017 PBS Schedule
15 February 2017 - In October and November 2016 the Department notified software vendors, pharmaceutical representative bodies and other stakeholders ...
Posted by Michael Wonder on 14 Feb 2017
Breast cancer pill denied to 500,000 women
14 February 2017 - Half a million women are being left at an increased risk of breast cancer ...